The HCPLive plaque psoriasis page is a resource for medical news and expert insights on psoriasis. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for psoriatic disease, and more.
April 24th 2024
A new study found intensive topical therapy improves deep sleep and REM sleep for patients with psoriasis and atopic dermatitis after 2 weeks.
Long-term Efficacy Observed in Patients with PsO Receiving Tildrakizumab
Patients with moderate to severe scalp psoriasis treated with tildrakizumab exhibited sustained efficacy through week 52, demonstrating the long-term effectiveness and safety profile of this treatment.
Tapinarof Cream 1% Rapidly Improves Mild to Severe Plaque Psoriasis
Patients with plaque psoriasis, including in intertriginous areas and genitalia, experienced rapid improvement when treated with tapinarof cream 1%, offering an effective and well-tolerated nonsteroidal option for this condition.
Tildrakizumab Significantly Improves Work Productivity in Moderate to Severe Plaque Psoriasis
Tildrakizumab significantly improved work productivity and reduced work activity impairment in patients with moderate to severe plaque psoriasis, highlighting this treatment's quality of life benefits.
Linda Stein Gold, MD: Nonsteroidal Topical Treatment for Psoriasis, Atopic Dermatitis
Linda Stein Gold, MD, discusses the notable transition in topical therapies for both psoriasis and atopic dermatitis, with the introduction of effective FDA-approved nonsteroidal treatments.
What Factors Should Clinicians Consider When Treating Psoriasis in Skin of Color?
Mona Shahriari, MD, and Andrew F Alexis, MD, MPH, discussed the multifaceted considerations dermatologists should weigh when treating patients with skin of color diagnosed with plaque psoriasis.
Improvements in Atopic Dermatitis from Ruxolitinib Treatment Observed Past Vehicle-Controlled Period
This new post-hoc analysis of ruxolitinib cream for those with eczema indicates that continued treatment past 8 weeks may lead to further benefit for those with the skin disease.